Login to Your Account



Washington Roundup

FDA Puts Final Polish on Proposed Biosimilar Fees

By Mari Serebrov
Washington Editor

Wednesday, December 7, 2011
WASHINGTON – Just in time for the debut in Congress, the FDA is putting the final touches on its first biosimilar user fee structure.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription